(Q34614573)

3 August 2017

title

Protocol for the MPTP mouse model of Parkinson's disease (English)

1 reference

3 August 2017

1 reference

2

Serge Przedborski

1 reference

3 August 2017

Vernice Jackson-Lewis

series ordinal

1

object named as

Vernice Jackson-Lewis

1 reference

3 August 2017

language of work or name

1 reference

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

2

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

141-151

1 reference

Parkinson's disease: mechanisms and models

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Proteasome inhibition and Parkinson's disease modeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

The impact of gender and estrogen on striatal dopaminergic neurotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

Cation-exchange high-performance liquid chromatography assay for the nigrostriatal toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.342

31 March 2020

Identifiers

DOI

10.1038/NPROT.2006.342

1 reference

Dimensions Publication ID

3 August 2017

1046349847

0 references

1 reference